ACMJ
Anatolian Current Medical Journal

Anatolian Current Medical Journal (ACMJ) is an unbiased, peer-reviewed, and open access international medical journal. The Journal publishes interesting clinical and experimental research conducted in all fields of medicine, interesting case reports, and clinical images, invited reviews, editorials, letters, comments, and related knowledge.

eISSN: 2718-0115
Creative Commons CC BY-NC-ND 4.0 International License.
EndNote Style

Submit Manuscript

Index
Original Article
Relationship between coronary artery disease and high-density lipoprotein cholesterol-monocyte ratio
Abstract
Aims: To investigate the association between high-density lipoprotein cholesterol (HDL-C)-to- monocyte ratio(HMR) and coronary artery disease (CAD) proven by coronary angiography.
Methods: A total of 311 patients were enrolled in the retrospective study. The grouping was based on whether the stenosis of one coronary artery exceeds 50%. Gensini Score (GS) to evaluate the severity of coronary artery stenosis. Spearman correlation analysis, progressive logistic regression, and receiver operating characteristic (ROC) curve analysis were used.
Results: The HMR difference between the CAD and non-CAD groups was statistically significant (P<0.001). Spearman correlation analysis showed that the HMR was slightly and moderately correlated with other independent risk factors of CAD (r<0.5). HMR was a new independent risk factor by progressive logistic regression analysis (odds ratio=0.784. 95% CI, 0.682-0.901). HMR was related to the GS of CAD patients (r=-0.244, P<0.001). Moreover, the HMR was better than HDL-C and HDL-C-to-cholesterol by comparing AUC (AUC HDL-C-to-monocyte=0.642, AUC HDL-C=0.603, AUC HDL-C-to-cholesterol=0.584).
Conclusion: HMR was an independent factor of CAD and can be used as a biomarker to evaluate the severity of CAD.

Keywords : Coronary artery disease, HDL-C-to-monocyte ratio, coronary angiography

Download Article


1. Falk E, Nakano M, Bentzon JF, Finn AV, Virmani R. Update onacute coronary syndromes: the pathologists&rsquo; view. Eur Heart J.2013;34(10):719-728.
2. Libby P, Ridker PM, Hansson GK. Inflammation inatherosclerosis: from pathophysiology to practice. J Am CollCardiol. 2009;54(23):2129-2138.
3. Ancuta P, Wang J, Gabuzda D. CD16+ monocytes produce IL-6, CCL2, and matrix metalloproteinase-9 upon interaction withCX3CL1-expressing endothelial cells. J Leukoc Biol. 2006;80(5):1156-1164.
4. Parthasarathy S, Barnett J, Fong LG. High-density lipoproteininhibits the oxidative modification of low-density lipoprotein.Biochim Biophys Acta. 1990;1044(2):275-283.
5. Executive summary of the third report of The National CholesterolEducation Program (NCEP) expert panel on detection, evaluation,and treatment of high blood cholesterol in adults (adult treatmentpanel III). JAMA. 2001;285(19):2486-2497.
6. Gensini GG. A more meaningful scoring system for determiningthe severity of coronary heart disease. Am J Cardiol. 1983;51:606.
7. Oishi Y, Wakatsuki T, Nishikado A, Oki T, Ito S. Circulatingadhesion molecules and severity of coronary atherosclerosis.Coron Artery Dis. 2000;11(1):77-81.
8. Montecucco F, Mach F. Atherosclerosis is an inflammatorydisease. Semin Immunopathol. 2009;31(1):1-3.
9. Pedicino D, Giglio AF, Galiffa VA, et al. Infections, immunity andatherosclerosis: pathogenic mechanisms and unsolved questions.Int J Cardiol. 2013;166(3):572-583.
10. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive proteinand other markers of inflammation in the prediction of cardiovasculardisease in women. N Engl J Med. 2000;342(12):836-843.
11. Taniguchi H, Momiyama Y, Ohmori R, et al. Associations ofplasma C-reactive protein levels with the presence and extent ofcoronary stenosis in patients with stable coronary artery disease.Atherosclerosis. 2005;178(1):173-177.
12. Kurtul A, Murat SN, Yarlioglues M, et al. Association of platelet-to-lymphocyte ratio with severity and complexity of coronaryartery disease in patients with acute coronary syndromes. Am JCardiol. 2014;114(7):972-978.
13. Kurtul S, Sarli B, Baktir AO, et al. Neutrophil to lymphocyteratio predicts SYNTAX score in patients with non-ST segmentelevation myocardial infarction. Int Heart J. 2015;56(1):18-21.
14. Danesh J, Kaptoge S, Mann AG, et al. Long-term interleukin-6 levelsand subsequent risk of coronary heart disease: two new prospectivestudies and a systematic review. PLoS Med. 2008;5(4):e78.
15. Ghattas A, Griffiths HR, Devitt A, Lip GY, Shantsila E. Monocytesin coronary artery disease and atherosclerosis: where are wenow? J Am Coll Cardiol. 2013;62(17):1541-1551.
16. Ley K, Miller YI, Hedrick CC. Monocyte and macrophagedynamics during atherogenesis. Arterioscler Thromb Vasc Biol.2011;31(7):1506-1516.
17. Badimon L, Padr&oacute; T, Vilahur G. Atherosclerosis, platelets andthrombosis in acute ischaemic heart disease. Eur Heart J AcuteCardiovasc Care. 2012;1(1):60-74.
18. Mehu M, Narasimhulu CA, Singla DK. Inflammatory cells inatherosclerosis. Antioxidants. 2022;11(2):233.
19. Li XP, Zhao SP, Zhang XY, Liu L, Gao M, Zhou QC. Protectiveeffect of high density lipoprotein on endothelium-dependentvasodilatation. Int J Cardiol. 2000;73(3):231-236.
20. Murphy AJ, Westerterp M, Yvan-Charvet L, Tall AR. Anti-atherogenic mechanisms of high density lipoprotein: effects onmyeloid cells. Biochim Biophys Acta. 2012;1821(3):513-521.
21. Karataş MB, &Ccedil;anga Y, &Ouml;zcan KS, et al. Monocyte to high-densitylipoprotein ratio as a new prognostic marker in patients withSTEMI undergoing primary percutaneous coronary intervention.Am J Emerg Med. 2016;34(2):240-244.
22. Akboga MK, Balci KG, Maden O, et al. Usefulness of monocyteto HDL-cholesterol ratio to predict high SYNTAX score inpatients with stable coronary artery disease. Biomark Med.2016;10(4):375-383.
23. Canpolat U, &Ccedil;etin EH, &Ccedil;etin S, et al. Association of monocyte-to-HDL cholesterol ratio with slow coronary flow is linked to systemicinflammation. Clin Appl Thromb Hemost. 2016;22(5):476-482.
24. &Ccedil;etin MS, &Ccedil;etin EHO, Kalender E, et al. Monocyte to HDLcholesterol ratio predicts coronary artery disease severity andfuture major cardiovascular adverse events in acute coronarysyndrome. Heart Lung Circ. 2016;25(11):1077-1086.
25. Li Y, Li S, Ma Y, Li J, Lin M, Wan J. Relationship betweennon-high-density lipoprotein cholesterol/apolipoprotein A-Iand monocyte/high-density lipoprotein cholesterol ratio andcoronary heart disease. Coron Artery Dis. 2020;31(7):623-627.
Article available in :
Volume 6, Issue 2, 2024
Page : 116-120
https://doi.org/10.38053/acmj.1409450
Article Information
Received : 25 Ara 2023
Accepted : 23 Oca 2024
Published : 08 Mar 2024
Corresponding Author :

Eyüp Özkan: Department of Cardiology, Başakşehir Çam & Sakura City Hospital, İstanbul, Turkiye

[email protected]
Citation : Özkan E, Erdoğan A. Relationship between coronary artery disease and high-density lipoprotein cholesterol-monocyte ratio. Anatolian Curr Med J. 2024;6(2):116-120.

Read: 785
Cited: 0
Download : 159
_Footer